Home

utställning Inaktuell organ alex och eva wallströms stiftelse för vetenskaplig forskning och utbildning darr Diskriminera etik

Nyhetsarkiv | Karolinska Institutet Nyheter
Nyhetsarkiv | Karolinska Institutet Nyheter

Ribonucleotide reductase inhibitors suppress SAMHD1 ara-CTPase activity  enhancing cytarabine efficacy. - Abstract - Europe PMC
Ribonucleotide reductase inhibitors suppress SAMHD1 ara-CTPase activity enhancing cytarabine efficacy. - Abstract - Europe PMC

Extracellular microvesicle microRNAs as predictive biomarkers for targeted  therapy in metastastic cutaneous malignant melanoma. - Abstract - Europe PMC
Extracellular microvesicle microRNAs as predictive biomarkers for targeted therapy in metastastic cutaneous malignant melanoma. - Abstract - Europe PMC

Emma R. Andersson - Principal Investigator (Associate Professor equivalent)  - Karolinska Institutet | LinkedIn
Emma R. Andersson - Principal Investigator (Associate Professor equivalent) - Karolinska Institutet | LinkedIn

Sex differences and risk factors for bleeding in Alagille syndrome | EMBO  Molecular Medicine
Sex differences and risk factors for bleeding in Alagille syndrome | EMBO Molecular Medicine

Nyhetsarkiv | Karolinska Institutet Nyheter
Nyhetsarkiv | Karolinska Institutet Nyheter

Nyhetsarkiv | Karolinska Institutet Nyheter
Nyhetsarkiv | Karolinska Institutet Nyheter

Nyhetsarkiv | Karolinska Institutet Nyheter
Nyhetsarkiv | Karolinska Institutet Nyheter

Sex differences and risk factors for bleeding in Alagille syndrome | EMBO  Molecular Medicine
Sex differences and risk factors for bleeding in Alagille syndrome | EMBO Molecular Medicine

Karolinska Institutets årsredovisning 2022
Karolinska Institutets årsredovisning 2022

Kathleen Grabert (0000-0002-5628-9400) - ORCID
Kathleen Grabert (0000-0002-5628-9400) - ORCID

Sex differences and risk factors for bleeding in Alagille syndrome | EMBO  Molecular Medicine
Sex differences and risk factors for bleeding in Alagille syndrome | EMBO Molecular Medicine

Sex differences and risk factors for bleeding in Alagille syndrome | EMBO  Molecular Medicine
Sex differences and risk factors for bleeding in Alagille syndrome | EMBO Molecular Medicine

Nyhetsarkiv | Karolinska Institutet Nyheter
Nyhetsarkiv | Karolinska Institutet Nyheter

Nyhetsarkiv | Karolinska Institutet Nyheter
Nyhetsarkiv | Karolinska Institutet Nyheter

Ribonucleotide reductase inhibitors suppress SAMHD1 ara-CTPase activity  enhancing cytarabine efficacy. - Abstract - Europe PMC
Ribonucleotide reductase inhibitors suppress SAMHD1 ara-CTPase activity enhancing cytarabine efficacy. - Abstract - Europe PMC

Proteiner som skyddar mot ledinflammation identifierade | Karolinska  Institutet Nyheter
Proteiner som skyddar mot ledinflammation identifierade | Karolinska Institutet Nyheter

Sex differences and risk factors for bleeding in Alagille syndrome | EMBO  Molecular Medicine
Sex differences and risk factors for bleeding in Alagille syndrome | EMBO Molecular Medicine

Närvarande Ledamöter Birgitta Henriques Normark, vicerektor, ordf Martin  Bergö, lärarrepresentant, vice ordf Catarina Almqvi
Närvarande Ledamöter Birgitta Henriques Normark, vicerektor, ordf Martin Bergö, lärarrepresentant, vice ordf Catarina Almqvi

Ribonucleotide reductase inhibitors suppress SAMHD1 ara-CTPase activity  enhancing cytarabine efficacy. - Abstract - Europe PMC
Ribonucleotide reductase inhibitors suppress SAMHD1 ara-CTPase activity enhancing cytarabine efficacy. - Abstract - Europe PMC

Ribonucleotide reductase inhibitors suppress SAMHD1 ara-CTPase activity  enhancing cytarabine efficacy. - Abstract - Europe PMC
Ribonucleotide reductase inhibitors suppress SAMHD1 ara-CTPase activity enhancing cytarabine efficacy. - Abstract - Europe PMC

IVA Aktuellt Nr 2 2013 by Kungl. Ingenjörsvetenskapsakademien, IVA - Issuu
IVA Aktuellt Nr 2 2013 by Kungl. Ingenjörsvetenskapsakademien, IVA - Issuu

Ribonucleotide reductase inhibitors suppress SAMHD1 ara-CTPase activity  enhancing cytarabine efficacy. - Abstract - Europe PMC
Ribonucleotide reductase inhibitors suppress SAMHD1 ara-CTPase activity enhancing cytarabine efficacy. - Abstract - Europe PMC

Emma R. Andersson - Principal Investigator (Associate Professor equivalent)  - Karolinska Institutet | LinkedIn
Emma R. Andersson - Principal Investigator (Associate Professor equivalent) - Karolinska Institutet | LinkedIn

Så är han som chef – stor intervju - Internwebben - Karolinska  Institutet
Så är han som chef – stor intervju - Internwebben - Karolinska Institutet

Ribonucleotide reductase inhibitors suppress SAMHD1 ara-CTPase activity  enhancing cytarabine efficacy. - Abstract - Europe PMC
Ribonucleotide reductase inhibitors suppress SAMHD1 ara-CTPase activity enhancing cytarabine efficacy. - Abstract - Europe PMC

Vi gratulerar Francesca Castoldi på BioNut | Karolinska Institutet Nyheter
Vi gratulerar Francesca Castoldi på BioNut | Karolinska Institutet Nyheter

Nyhetsarkiv | Karolinska Institutet Nyheter
Nyhetsarkiv | Karolinska Institutet Nyheter